AC Immune
Clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases. Learn more
Launch date
Employees
Market cap
$315m
Enterprise valuation
$113m (Public information from Sep 2024)
Share price
$3.69 ACIU
Company register number CH-270.4.013.417-2
Lausanne Canton of Vaud (HQ)
Authorizing premium user...